Cyient DLM (CYIENTDLM) Q2 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 25/26 earnings summary
24 Sep, 2026Executive summary
Q2 FY26 showed sustained positive momentum in order intake, margin, and cash flow, with new global clients added and strategic focus on India and global expansion.
Large deals are in the pipeline, with ongoing M&A exploration and technology investments to expand global presence.
Approved unaudited consolidated and standalone financial results for Q2 and H1 FY26; appointed Dr. Ganesh Natarajan as Independent Director.
Financial highlights
Q2 FY26 revenue was INR 3,106.34 million, down 20.2% YoY but up sequentially; EBITDA was INR 312 million, nearly flat YoY.
Reported PAT surged 108% YoY to INR 321.45 million, driven by a one-off earnout reversal; normalized PAT margin was 4%.
Order intake for Q2 was nearly INR 500 crore, with cumulative H1 order intake crossing INR 1,000 crore, up 130% YoY; order backlog reached INR 22,911 million.
Free cash flow was positive for the fourth consecutive quarter, with operational FCF at INR 46 crore; normalized FCF for Q2 was INR 460 million after land acquisition cost.
Basic EPS for Q2 FY26 was ₹4.05, up from ₹0.94 in Q1 FY26.
Outlook and guidance
H2 outlook is promising, with expectations of continued order momentum and margin improvement; year-on-year growth expected to resume from Q4 FY26.
Focus on account mining, expanding B2S offerings, and inorganic growth via acquisitions in NAM and EMEA.
No formal FY27 guidance yet, but early indicators are positive.
Management notes current and prior period numbers may not be strictly comparable due to an acquisition in Q3 FY25.
Latest events from Cyient DLM
- Q2 FY25 revenue up 33.4% YoY, with Altek acquisition boosting US growth and future EPS.CYIENTDLM
Q2 24/25 - Q3 FY25 revenue surged 38.4% YoY with Altek integration and robust order backlog.CYIENTDLM
Q3 24/25 - Q4 FY25 saw record margins and growth, led by Altek integration and US expansion.CYIENTDLM
Q4 24/25 - Revenue and EBITDA grew with record order intake, but PAT and EPS declined YoY.CYIENTDLM
Q1 25/26 - Q3 FY26 revenue fell 31.7% YoY, but EBITDA margin rose to 10.2% with a strong order backlog.CYIENTDLM
Q3 25/26 - FY26 ended with record order book, improved margins, and strong profit despite revenue volatility.CYIENTDLM
Q4 25/26 - Record revenue and profit growth, robust order book, and expansion into AI and robotics.CYIENTDLM
Q1 26/27